Clinical trial
Single Dose Preliminary Dose-ranging and Safety in Patients With COPD
NCT01809262 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Dose Preliminary Dose-ranging and Safety in Patients With COPD
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- November 30, 2006
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.